GYC-22202-98269 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-23
Dose 1 — Pfizer-BioNTech
2022-06-27
Registered in v-safe
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-07
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-14
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-21
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-22
Health check-in — 3 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-12-22
Health check-in — 6 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-06-23
Survey response — 12 months, dose 1, under 3
MedDRA: Exposure to SARS-CoV-2, Lethargy, Pyrexia — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-23	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Exposure to SARS-CoV-2	·	·	✓
SD	Lethargy	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release